États-Unis - anglais - NLM (National Library of Medicine)

meridian medical technologies® llc - atropine (unii: 7c0697dr9i) (atropine - unii:7c0697dr9i) - atropine 2.1 mg in 0.7 ml - duodote is indicated for the treatment of poisoning by organophosphorus nerve agents as well as organophosphorus insecticides in adults and pediatric patients weighing more than 41 kg (90 pounds). none. risk summary atropine readily crosses the placental barrier and enters fetal circulation. there are no adequate data on the developmental risk associated with the use of atropine, pralidoxime, or the combination in pregnant women. adequate animal reproduction studies have not been conducted with atropine, pralidoxime, or the combination. in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2-4% and 15-20%, respectively. risk summary atropine has been reported to be excreted in human milk. it is not known whether pralidoxime is excreted in human milk. there are no data on the effects of atropine or pralidoxime on the breastfed infant or the effects of the drugs on milk production. the developmental and health benefits

Nouvelle-Zélande - anglais - Medsafe (Medicines Safety Authority)

pharmaco (nz) ltd - ocriplasmin 2.5 mg/ml - concentrate for injection - 2.5 mg/ml - active: ocriplasmin 2.5 mg/ml excipient: citric acid monohydrate mannitol sodium hydroxide water for injection - jetrea is indicated in adults for the treatment of vitreomacular traction (vmt), including when associated with macular hole of diameter less than or equal to 400 microns.

Canada - anglais - Health Canada

meridian medical technologies inc. - diazepam - liquid - 10mg - diazepam 10mg - benzodiazepines

États-Unis - anglais - NLM (National Library of Medicine)

meridian medical technologies, inc. - hydroxocobalamin (unii: q40x8h422o) (hydroxocobalamin - unii:q40x8h422o) - hydroxocobalamin 5 g in 250 ml - cyanokit is indicated for the treatment of known or suspected cyanide poisoning. none risk summary available data from cases reported in the published literature and postmarketing surveillance with cyanokit use in pregnant women are insufficient to identify a drug-associated risk for major birth defects, miscarriage, or adverse maternal and fetal outcomes. there are risks to the pregnant woman and fetus associated with untreated cyanide poisoning (see clinical considerations) . in animal studies, hydroxocobalamin administered to pregnant rats and rabbits during the period of organogenesis caused skeletal and soft tissue abnormalities, including alterations in the central nervous system, at exposures similar to human exposures at the therapeutic dose (see data) . the estimated background risk of major birth defects and miscarriage for the indicated population is unknown. all pregnancies have a background risk of birth defect, loss, or other adverse outcomes. in the u.s. general population, the estimated backgr

États-Unis - anglais - NLM (National Library of Medicine)

deseret biologicals - cholesterol (unii: 97c5t2uq7j) (cholesterol - unii:97c5t2uq7j), histamine dihydrochloride (unii: 3poa0q644u) (histamine - unii:820484n8i3), menadione (unii: 723jx6cxy5) (menadione - unii:723jx6cxy5), pyrrole (unii: 86s1zd6l2c) (pyrrole - unii:86s1zd6l2c), .alpha.-lipoic acid (unii: 73y7p0k73y) (.alpha.-lipoic acid - unii:73y7p0k73y), ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), adenosine triphosphate disodium (unii: 5l51b4dr1g) (adenosine triphosphate - unii:8l70q75fxe), bos ta - cholesterol 6 [hp_x] in 1 ml - temporary relief of symptoms related to indigestion, anxiety, pain.** **these statements are based upon homeopathic principles. they have not been reviewed by the food and drug administration. temporary relief of symptoms related to indigestion, anxiety, pain.** **these statements are based upon homeopathic principles. they have not been reviewed by the food and drug administration.

États-Unis - anglais - NLM (National Library of Medicine)

deseret biologicals - cholesterol (unii: 97c5t2uq7j) (cholesterol - unii:97c5t2uq7j), histamine dihydrochloride (unii: 3poa0q644u) (histamine - unii:820484n8i3), menadione (unii: 723jx6cxy5) (menadione - unii:723jx6cxy5), pyrrole (unii: 86s1zd6l2c) (pyrrole - unii:86s1zd6l2c), .alpha.-lipoic acid (unii: 73y7p0k73y) (.alpha.-lipoic acid - unii:73y7p0k73y), ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), adenosine triphosphate disodium (unii: 5l51b4dr1g) (adenosine triphosphate - unii:8l70q75fxe), bos taurus bi - cholesterol 6 [hp_x] in 1 ml - temporary relief of symptoms related to energy weakness in the gallbladder/liver area such as indigestion, chronic digestive disorders, anxiety and pain. temporary relief of symptoms related to energy weakness in the gallbladder/liver area such as indigestion, chronic digestive disorders, anxiety and pain.

États-Unis - anglais - NLM (National Library of Medicine)

meridian medical technologies, llc - atropine (unii: 7c0697dr9i) (atropine - unii:7c0697dr9i) - atropine 2.1 mg in 0.7 ml - atnaa is indicated for the treatment of poisoning by susceptible organophosphorus nerve agents having anticholinesterase activity in adults. none. risk summary atropine readily crosses the placental barrier and enters fetal circulation. there are no adequate data on the developmental risk associated with the use of atropine, pralidoxime chloride, or the combination in pregnant women. adequate animal reproduction studies have not been conducted with atropine, pralidoxime chloride, or the combination. in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2-4% and 15-20%, respectively. risk summary atropine has been reported to be excreted in human milk. it is not known whether pralidoxime chloride is excreted in human milk. there are no data on the effects of atropine or pralidoxime chloride on the breastfed infant or the effects of the drugs on milk production. the developmental and health benefits of breastfeeding should be

États-Unis - anglais - NLM (National Library of Medicine)

meridian medical technologies llc - atropine (unii: 7c0697dr9i) (atropine - unii:7c0697dr9i) - atropine sulfate 0.25 mg in 0.3 ml - atropen is indicated for the treatment of poisoning by susceptible organophosphorus nerve agents having cholinesterase activity as well as organophosphorus or carbamate insecticides in adult and pediatric patients. none. risk summary atropine readily crosses the placental barrier and enters fetal circulation. there are no adequate data on the developmental risk associated with the use of atropine in pregnant women. adequate animal reproduction studies have not been conducted with atropine. in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2% to 4% and 15% to 20%, respectively. risk summary atropine has been reported to be excreted in human milk. there are no data on the effects of atropine on the breastfed infant or the effects of the drug on milk production. the developmental and health benefits of breastfeeding should be considered along with the mother's clinical need for atropen and any potential adverse effects on

États-Unis - anglais - NLM (National Library of Medicine)

apotheca company - aloe (unii: v5vd430yw9) (aloe - unii:v5vd430yw9), aluminum oxide (unii: lmi26o6933) (aluminum oxide - unii:lmi26o6933), apis mellifera (unii: 7s82p3r43z) (apis mellifera - unii:7s82p3r43z), arsenic trioxide (unii: s7v92p67ho) (arsenic cation (3+) - unii:c96613f5av), barium carbonate (unii: 6p669d8hq8) (barium cation - unii:v645272hln), bryonia alba root (unii: t7j046yi2b) (bryonia alba root - unii:t7j046yi2b), activated charcoal (unii: 2p3vwu3h10) (activated charcoal - unii:2p3vwu3h10), matricaria re - aloe 30 [hp_c] in 1 ml - indications:   for temporary relief of tickling cough, hoarseness, suffocative tightness in chest, asthma, constricted air passages, hay fever, headache, eye pain, constipation, swollen glands, fluid retention, abdominal pain, indigestion, diarrhea, right shoulder pain and shoulder blade pain. indications:   for temporary relief of tickling cough, hoarseness, suffocative tightness in chest, asthma, constricted air passages, hay fever, headache, eye pain, constipation, swollen glands, fluid retention, abdominal pain, indigestion, diarrhea, right shoulder pain and shoulder blade pain.

États-Unis - anglais - NLM (National Library of Medicine)

apotheca company - arsenic trioxide (unii: s7v92p67ho) (arsenic cation (3+) - unii:c96613f5av), oyster shell calcium carbonate, crude (unii: 2e32821g6i) (oyster shell calcium carbonate, crude - unii:2e32821g6i), silybum marianum seed (unii: u946sh95ee) (silybum marianum seed - unii:u946sh95ee), ceanothus americanus leaf (unii: 25b1y14t8n) (ceanothus americanus leaf - unii:25b1y14t8n), cinchona officinalis bark (unii: s003a158sb) (cinchona officinalis bark - unii:s003a158sb), digitalis (unii: f1t8qt9u8b) (digitalis - uni - arsenic trioxide 30 [hp_c] in 1 ml - indications:   for temporary relief of vomiting, stomach pain, loss of appetite, abdominal bloating, loose stools, fluid retention, and urine retention.  functional disorders of the spleen including enlarged and painful liver and spleen, poor circulation, pain in abdomen and behind lower ribs in evening. indications:   for temporary relief of vomiting, stomach pain, loss of appetite, abdominal bloating, loose stools, fluid retention, and urine retention.  functional disorders of the spleen including enlarged and painful liver and spleen, poor circulation, pain in abdomen and behind lower ribs in evening.